About: EFPIA

Health 03-07-2018

EFPIA President: Next EU Commission should prioritise competitiveness in pharma innovation

The next European Commission should focus on the bloc’s role in the global context of innovation, as China is “decisive” about creating a reliable framework for intellectual property and connecting biotech start-ups and digital companies, EFPIA’s President Stefan Oschmann told EURACTIV.com in an interview.  
Health 07-05-2018

Pharma boss: Incentives based on outcomes will optimise EU healthcare

An outcomes-based approach for incentives in the pharmaceutical sector would help optimise the entire healthcare systems, Nathalie Moll told EURACTIV.com in an interview.
Health 07-12-2017

Celgene boss: Chronic diseases will bankrupt Europe if incentives are dropped

Alzheimers, diabetes, cancer and other non-communicable diseases will bankrupt Europe if we don’t keep the incentive frameworks alive and well, Mark Alles told EURACTIV.com in an interview.
Health 10-10-2017

Pharma boss: Targeting drugs won’t make healthcare systems more sustainable

“Salami-slicing” the cost of medicines, which represent almost one-fifth of health system budgets and are subject to rigorous value assessments, won’t make healthcare systems more sustainable in the future, Nathalie Moll told EURACTIV.com in an interview.
Health 14-03-2011

Pharma chief: Europe must not fall behind US, emerging countries

Brian Ager, Director-General of the European Federation of Pharmaceutical Industries and Associations (EFPIA), is leaving his position after 16 years at the head of the trade association. In an interview with EURACTIV, he reflects on his tenure and discusses some of the new legislation and controversies affecting the pharmaceutical industry.

Want to know what's going on in the EU Capitals daily? Subscribe now to our new 9am newsletter.